1 February 2022 in International Journal of General Medicine
Background: Cervical cancer is one of the leading causes of death in women. Among the sodium ion channels associated with cancer development, voltage gated sodium channel plays an important role in pathophysiology of cervical cancer; however, the clinicopathological implication of epithelial sodium channel (ENaC) has not been explored. Purpose: This study focused on identifying dysregulation of ENaC encoding genes, including SCNN1A, SCNN1B, and SCNN1G, and their relationship with clinicopathologic features in cervical cancer patients. Materials and Methods: RNA sequencing data of ENaC-encoding genes, clinicopathologic data, and survival data of cervical cancer patients were obtained from The Cancer Genome Atlas cohort. Microarray data of ENaC-encoding genes were obtained from Gene Expression Omnibus datasets: GSE6791 and GSE63514. Results: The expression levels of SCNN1A, SCNN1B, and SCNN1G were positively correlated with each other. SCNN1A, SCNN1B, and SCNN1G are significantly overexpressed in normal tissues than in tumor tissues. Survival analysis showed that simultaneous overexpression of all three genes associated with better overall survival (OS). Each overexpression of SCNN1B and SCNN1G was significantly associated with better OS. Moreover, each expression level of SCNN1A, SCNN1B, and SCNN1G was negatively correlated with histologic grade of tumor. Conclusion: ENaC-encoding genes might be potential biological markers to better predict survival outcomes in cervical cancer patients.
31 January 2022 in Anesthesia and Pain Medicine
BackgroundSpontaneous intracranial hypotension occurs due to cerebrospinal fluid leakage from the spinal column, and orthostatic headache is the most common clinical presentation. Recent studies showed that bilateral greater occipital nerve blockade demonstrated clinical efficacy in relieving post-dural puncture headache after caesarean section. CaseA 40-year-old male who presented severe orthostatic headache was consulted to our pain clinic from neurology department. He initially felt a dull nature pain over the whole occipital area which then spread over the frontal and parietal areas. His headache was combined with nausea and vomiting. An epidural blood patch was delayed until final cisternography, and bilateral greater occipital nerve blockade using ultrasound guidance was performed instead. After the blockade, the previously existing headache around the occipital and parietal areas disappeared completely, but mild headache persisted around the frontal area.ConclusionsGreater occipital nerve blockade could be a good therapeutic alternative to improve headache resulting from spontaneous intracranial hypotension.
15 April 2026 in SSRN Electronic Journal
Background: Repeated outpatient interventions for chronic conditions are vulnerable to treatment continuation beyond clinical necessity, yet no objective, modality-agnostic metric exists for monitoring treatment density relative to clinical trajectory. We developed the Treatment Density Index (TDI) and evaluated its ability to discriminate appropriate tapering from persistent overtreatment.Methods: We conducted an in-silico simulation generating 1,000 synthetic patient episodes across two scenarios: Scenario A (Normal Tapering; n=500), with visit intervals progressively expanding from 1–2 to 6–8 weeks; and Scenario B (Persistent Dense Treatment; n=500), maintaining fixed 1–2 week intervals throughout 365 days. TDI was calculated as , where denotes visits within an 84-day rolling window and denotes capped elapsed days, classified into four zones: Green (<3·0), Yellow (3·0–6·0), Red (6·0–9·0), and Lock (≥9·0). Between-scenario differences were assessed using Mann–Whitney U and chi-square tests.Findings: At 12 weeks, median TDI was 3·0 (IQR 0·3–3·9) in Scenario A versus 8·1 (IQR 7·7–9·4) in Scenario B (p<0·0001), despite comparable values at 4 weeks (p=0·811). Zone distributions differed markedly: 67·7% of Scenario A visits were Green-zone and none reached Lock zone, whereas 84·2% of Scenario B visits were Red or Lock (χ²=15,685·5, p<0·0001). Peak TDI correlated moderately-to-strongly with visit count, rate, and interval (|ρ|=0·595–0·673; all p<0·0001).Interpretation: TDI reliably discriminated appropriate from excessive treatment density, with discriminative capacity strengthening over time. The zone-based framework provides a clinically actionable monitoring signal deployable within existing electronic health record infrastructures. Prospective validation against clinical outcomes is required before implementation.
30 October 2021 in Anesthesia and Pain Medicine
BackgroundGasserian ganglion radiofreqeucy thermoablation is a good treatment option for the management of pain in trigeminal neuralgia. We report a case in which the patient of trigeminal neuralgia combined with anterior cerebral artery aneurysm was treated successfully by gasserian ganglion thermoablation without any complication.CaseAn 85-year-old female presenting with electric shock like sensation in the gum and molar teeth was diagnosed as trigeminal neuralgia. Carbamazepine medication and trigeminal nerve blockade relieved her pain partially, but severe side effects of carbamazepine occurred. Magnetic resonance angiography of the brain showed saccular aneurysm in inferior aspect of the anterior communicating artery. Gasserian ganglion thermoablation under sedation anesthesia using nicardipine was performed carefully without any rupture of the cerebral aneurysm.ConclusionsGasserian ganglion thermoablation could be performed safely in a patient with cerebral aneurysm without any inadvertent event.